National Health Investors, Inc.

NHI Real Estate Reit Healthcare Facilities

National Health Investors, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $375.6 million, up 12.1% from fiscal 2024.

Revenue
+33.8%
EPS
+45.6%
Free cash flow
+2,585.5%
Total debt
+13.9%

Quarter to June 2026, against a year earlier

71.11 0.47 −0.66%
Market cap
$3.5B
P/E
20.5×
Fwd P/E
16.5×
Dividend yield
5.20%
F-score
5/9
Altman Z
n/a
Beneish M
n/a
Dividend safety
n/a

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Revenue
375.63 335.18 319.84 278.19 298.72 332.81 318.08 294.61 278.66 248.46
Revenue Growth
12.07% 4.80% 14.97% (6.87%) (10.24%) 4.63% 7.97% 5.72% 12.15% 8.52%
Gross Profit
314.70 292.93 280.25 250.00 298.72 332.81 318.08 294.61 278.66 248.46
Operating Income
195.61 183.20 177.12 81.26 133.39 223.93 217.57 204.13 197.82 161.88
EBT
140.79 136.64 134.38 65.50 111.97 185.31 160.45 154.33 159.37 152.72
Income after Tax
140.79 136.64 134.38 65.50 111.97 185.31 160.45 154.33 159.37 152.72
Net Income Common
141.98 137.87 135.60 66.40 111.80 185.13 160.46 154.33 159.37 151.54
EPS (Diluted)
3.02 3.13 3.13 1.48 2.44 4.14 3.67 3.67 3.87 3.87
Shares (Diluted, Weighted)
47.05 44.10 43.39 44.79 45.73 44.70 43.70 42.09 41.15 39.16
Gross Margin
83.78% 87.39% 87.62% 89.87% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
EBIT Margin
52.07% 54.66% 55.38% 29.21% 44.65% 67.28% 68.40% 69.29% 70.99% 65.15%
Net Profit Margin
37.80% 41.13% 42.40% 23.87% 37.43% 55.62% 50.45% 52.39% 57.19% 60.99%
Free Cash Flow Margin
(15.30%) 16.71% 60.01% 123.40% 133.70% 46.59% 1.18% 20.44% 8.16% (76.62%)
EBITDA
281.96 261.20 251.85 163.10 218.84 312.59 299.86 279.64 270.38 224.31
EBIT
195.61 183.20 177.12 81.26 133.39 223.93 217.57 204.13 197.82 161.88

Show all line items

In millions of $ except per-share values · columns are period end dates